These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6890710)

  • 1. A family with reduced plasminogen activator activity in blood associated with recurrent venous thrombosis.
    Jørgensen M; Mortensen JZ; Madsen AG; Thorsen S; Jacobsen B
    Scand J Haematol; 1982 Sep; 29(3):217-23. PubMed ID: 6890710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thrombosis and tissue plasminogen activator release deficiency: a family study.
    Patrassi GM; Sartori MT; Viero ML; Boscaro M; Boeri G; Girolami A
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):231-5. PubMed ID: 1909902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.
    Nilsson IM; Ljungnér H; Tengborn L
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1453-6. PubMed ID: 3922531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A family with reduced plasminogen activator activity in the blood associated with recurrent thrombosis].
    Jørgensen M; Mortensen JZ; Madsen AG; Thorsen S; Jacobsen B
    Ugeskr Laeger; 1983 Jul; 145(30):2302-3. PubMed ID: 6685363
    [No Abstract]   [Full Text] [Related]  

  • 5. Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factor.
    Stead NW; Bauer KA; Kinney TR; Lewis JG; Campbell EE; Shifman MA; Rosenberg RD; Pizzo SV
    Am J Med; 1983 Jan; 74(1):33-9. PubMed ID: 6401391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis.
    Jørgensen M; Bonnevie-Nielsen V
    Br J Haematol; 1987 Feb; 65(2):175-80. PubMed ID: 3103670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A family with thromboembolic disease associated with deficient fibrinolytic activity in vessel wall.
    Johansson L; Hedner U; Nilsson IM
    Acta Med Scand; 1978; 203(6):477-80. PubMed ID: 665314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoradiometric determination of blood/tissue plasminogen activators in thrombophilia].
    Astedt B; Fagner U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):475-9. PubMed ID: 6083913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenformin and ethyloestrenol in recurrent venous thrombosis.
    Nilsson IM; Hedner U; Isacson S
    Acta Med Scand; 1975; 198(1-2):107-13. PubMed ID: 1166815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. delta 4-ethylestrenol in recurrent deep venous thrombosis.
    Nilsson B; Nilsson IM; Hedner U
    Acta Med Scand; 1981; 209(1-2):45-9. PubMed ID: 7193965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial clustering of defective release of t-PA.
    Petäjä J; Rasi V; Vahtera E; Myllylä G
    Br J Haematol; 1991 Oct; 79(2):291-5. PubMed ID: 1958488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disorders in the release of plasminogen activators].
    Brommer EJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):198-207. PubMed ID: 2427402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial elevation of plasma histidine-rich glycoprotein. A case associated with recurrent venous thrombosis and high PAI-1 levels.
    Falkon L; Gari M; Montserrat I; Borrell M; Fontcuberta J
    Thromb Res; 1992 May; 66(2-3):265-70. PubMed ID: 1412197
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasminogen activator in nephrotic syndrome.
    Andreenko GV; Podoroldskaya LV; Polyantseva LP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):351-5. PubMed ID: 2465229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies of the antithrombin III level and plasminogen activator activity in patients with thrombophlebitis].
    Tymiński W; Czestochowska E; Swiecicki P
    Pol Tyg Lek; 1985 Oct; 40(43):1202-4. PubMed ID: 4088936
    [No Abstract]   [Full Text] [Related]  

  • 16. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of local exercise and vessel occlusion on fibrinolytic activity.
    Rennie JA; Bennett B; Ogston D
    J Clin Pathol; 1977 Apr; 30(4):350-2. PubMed ID: 856879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of protein S deficiency with thrombosis in a kindred with increased levels of plasminogen activator inhibitor-1.
    Bolan CD; Krishnamurti C; Tang DB; Carrington LR; Alving BM
    Ann Intern Med; 1993 Oct; 119(8):779-85. PubMed ID: 8379599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration in fibrinolytic capacity after operation.
    Griffiths NJ; Woodford M; Irving MH
    Lancet; 1977 Sep; 2(8039):635-7. PubMed ID: 71450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Poor fibrinolytic response to venous occlusion: defect of endothelial cells or plasma interference?].
    Stalder M; Hauert J; Bachmann F
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1462-4. PubMed ID: 6606226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.